Study guide

4.1 Diagnostic Protocols: Adult PSG, Pediatric Testing & HSAT

BRPT Certified Polysomnographic Technician CPSGT

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: CPSGT Overview, Eligibility & Credentialing

1.1 CPSGT Exam Structure, Scoring & Test Logistics 1.2 Eligibility Pathways, STAR Programs & Application Requirements 1.3 Scope of Practice, Credential Progression & Ethics

2 Chapter 2: Patient Assessment, Clinical Intake & Medication Effects

2.1 Clinical Indications & Physician Order Verification 2.2 Clinical History, Screening Tools & Physical Assessment 2.3 Pharmacological Effects on Sleep Architecture & Waveforms

3 Chapter 3: International 10-20 System, Montage Setup & Bio-Calibrations

3.1 International 10-20 System Cranial Landmarks & Measurements 3.2 Recommended EEG Derivations & EOG Placements 3.3 Chin EMG, Leg EMG, ECG & Respiratory Sensor Montages 3.4 Skin Preparation, Impedance Optimization & Bio-Calibrations

4 Chapter 4: Testing Protocols, Signal Processing & Artifact Management

4.1 Diagnostic Protocols: Adult PSG, Pediatric Testing & HSAT 4.2 Daytime Sleep Testing Protocols: MSLT & MWT 4.3 Signal Processing: Filters, Sampling Rates & Display Parameters 4.4 Artifact Recognition, Troubleshooting & ECG Dysrhythmias

5 Chapter 5: Sleep Staging, Arousal Rules & Physiologic Event Scoring

5.1 AASM Adult Sleep Stage Scoring Rules 5.2 Pediatric Sleep Staging & AASM EEG Arousal Rules 5.3 AASM Respiratory Event Scoring Rules 5.4 Movement Disorders, Parasomnias & Neurological Events

6 Chapter 6: Polysomnographic Calculations, Indices & Data Reporting

6.1 Sleep Architecture, Latency & Efficiency Calculations 6.2 Respiratory Indices & OSA Severity Grading 6.3 Oxygenation, Arousal & Periodic Limb Movement Indices 6.4 Comprehensive Technologist Morning Reporting & Quality Assurance

7 Chapter 7: PAP Modalities, Titration Protocols & Troubleshooting

7.1 PAP Therapy Modalities, Mechanics & Interface Selection 7.2 AASM CPAP & BiPAP Titration Protocols and Algorithms 7.3 Split-Night Protocols & AASM Titration Quality Grading 7.4 PAP Troubleshooting, Leaks & Side Effect Management

8 Chapter 8: Supplemental Oxygen, Patient Safety & Professional Practice

8.1 Supplemental Oxygen Titration & Delivery Protocols 8.2 In-Lab Medical Emergencies & Clinical Response Protocols 8.3 Electrical Safety, Environmental Protocols & Infection Control 8.4 Patient Communication, HIPAA & Professional Ethics

4.1 Diagnostic Protocols: Adult PSG, Pediatric Testing & HSAT

Key Takeaways Explain This Topic AI

Standard adult diagnostic polysomnography (Type I PSG) requires a minimum recording duration of 6 hours (360 minutes), continuous synchronized low-light video/audio monitoring, standardized acoustic and thermal environmental controls, and pre-study/post-study biocalibrations.

Pediatric polysomnography requires specialized clinical modifications including mandatory continuous parent/caregiver presence, age-appropriate sensor sizing, behavioral desensitization, and continuous non-invasive carbon dioxide monitoring (EtCO2 or TcCO2) to detect alveolar hypoventilation.

Home Sleep Apnea Testing (HSAT) is categorized under the SCOPER framework, with Type III devices requiring a minimum of 4 physiological channels (2 respiratory, 1 cardiac/pulse rate, 1 oximetry) and Type IV devices monitoring 1 to 2 parameters.

HSAT is clinically indicated solely for adult patients with a high pre-test probability of uncomplicated moderate-to-severe OSA and is strictly contraindicated in patients with significant comorbid pulmonary disease, heart failure, neuromuscular disorders, central sleep apnea, insomnia, or pediatric patients.

Because HSAT lacks EEG channels, it cannot determine Total Sleep Time (TST) or sleep architecture; it calculates the Respiratory Event Index (REI) based on total monitoring time, leading to potential underestimation of OSA severity, and technically inadequate or negative HSATs require follow-up in-laboratory PSG.

Last updated: August 2026

4.1 Diagnostic Protocols: Adult PSG, Pediatric Testing & HSAT

In clinical sleep medicine, diagnostic testing protocols establish the physiological baseline required to diagnose sleep-disordered breathing, movement disorders, parasomnias, and disorders of hypersomnolence. On the Certified Polysomnographic Technician (CPSGT) examination, technicians must master the operational differences, technical standards, patient preparation workflows, and clinical limitations distinguishing attended in-laboratory adult polysomnography (Type I PSG) , pediatric polysomnography , and Home Sleep Apnea Testing (HSAT / Type III & IV devices) .

1. Adult Diagnostic Polysomnography (Type I PSG) Protocol

Attended, in-laboratory polysomnography represents the gold standard diagnostic modality in sleep medicine. The American Academy of Sleep Medicine (AASM) Manual for the Scoring of Sleep and Associated Events establishes strict technical criteria for baseline diagnostic recordings. +-----------------------------------------------------------------------------+

  • | AASM ATTENDED DIAGNOSTIC PSG (TYPE I) STANDARDS |
  • | |
  • | RECORDING DURATION: Minimum 6.0 hours (360 min) of recording time (TRT)|
  • | Optimal: 7.0 to 8.0 hours based on habitual sleep |
  • | |
  • | ENVIRONMENTAL CONTROLS: |
  • | - Ambient Temperature: 68°F to 72°F (20°C to 22°C), individually set |
  • | - Acoustic Isolation: < 30 to 35 dB ambient background sound level |
  • | - Lighting: Total light extinction during sleep period |
  • | - Video / Audio: Continuous synchronized low-light IR video & audio |
  • | |
  • | CORE PHYSIOLOGICAL CHANNELS (>= 7 MANDATORY PARAMETERS): |
  • | [1] Electroencephalography (EEG): F4-M1, C4-M1, O2-M1 (backups: F3, C3, O1)|
  • | [2] Electrooculography (EOG): E1-M2, E2-M2 |
  • | [3] Electromyography (EMG): Chin (mental/submental) & Tibialis|
  • | [4] Electrocardiography (ECG): Single-lead modified Lead II |
  • | [5] Respiratory Airflow: Thermal sensor (apneas) & Nasal |
  • | pressure transducer (hypopneas) |
  • | [6] Respiratory Effort: Dual RIP belts (ribcage & abdomen)|
  • | [7] Oxygen Saturation (SpO2): Pulse oximeter (<= 3s averaging) |
  • | [8] Supplementary: Snore sensor, Body position sensor|
  • +-----------------------------------------------------------------------------+

Clinical Execution & In-Study Workflow:

Patient Intake & Habitual Scheduling: The patient should arrive at the sleep center 1.5 to 2 hours before their habitual bedtime to allow unhurried clinical orientation, questionnaire completion, skin preparation, and electrode application.

Pre-Study Biocalibrations: Conducted immediately prior to "Lights Out" with the patient resting quietly in bed (eyes open, eyes closed, look left/right/up/down, blink, clench jaw, flex feet, inhale/exhale, hold breath) to verify signal integrity, polarity, and filter responses.

Lights Out to Lights On: Technicians continuously monitor the acquisition console, documenting body position shifts, sleep staging transitions, respiratory events, cardiac dysrhythmias, and patient room entries. Minimum recording duration must reach at least 6 hours (360 minutes) to capture sufficient NREM and REM sleep cycles across both supine and lateral postures.

Post-Study Biocalibrations & Discharge: Upon "Lights On," repeat the biocalibration sequence to verify that electrodes and sensors remained functional throughout the entire night before removing leads and cleaning the patient's scalp.

2. Pediatric Polysomnography Modifications

Pediatric patients (infants, children, and adolescents under 18 years of age) possess distinct neurodevelopmental, physiological, and anatomical characteristics that necessitate specialized monitoring protocols. +-----------------------------------------------------------------------------+

  • | PEDIATRIC POLYSOMNOGRAPHY SPECIAL PROTOCOLS |
  • | |
  • | [CAREGIVER LODGING] Mandatory presence of parent/guardian in the room |
  • | [CARBON DIOXIDE] MANDATORY continuous EtCO2 or TcCO2 capnography |
  • | [SENSOR SIZING] Pediatric-sized nasal prongs & calibrated RIP belts|
  • | [PULSE OXIMETRY] Fast averaging time (<= 3 seconds) for desaturations|
  • | [BEHAVIORAL PREP] Desensitization, medical play, Surgilast lead secure|
  • +-----------------------------------------------------------------------------+

Critical Pediatric Technical Adaptations:

Continuous Carbon Dioxide Monitoring ( E t C O 2 EtCO_2 EtC O 2 ​ / T c C O 2 TcCO_2 T c C O 2 ​ ):

AASM Mandatory Standard: Continuous non-invasive assessment of alveolar ventilation via End-Tidal C O 2 CO_2 C O 2 ​ ( E t C O 2 EtCO_2 EtC O 2 ​ ) or Transcutaneous C O 2 CO_2 C O 2 ​ ( T c C O 2 TcCO_2 T c C O 2 ​ ) is required for all pediatric diagnostic sleep studies.

Clinical Rationale: Children frequently exhibit sleep-related hypoventilation or prolonged partial upper airway obstruction without discrete apneas. Obstructive hypoventilation in pediatrics produces progressive hypercapnia ( C O 2 CO_2 C O 2 ​ retention) and hypoxemia rather than classic adult cyclic discrete obstructive events.

Pediatric Hypoventilation Criteria: C O 2 CO_2 C O 2 ​ levels exceeding 50 mmHg 50\text{ mmHg} 50 mmHg for > 25 % > 25\% > 25% of Total Sleep Time (TST) , or a peak C O 2 > 53 mmHg CO_2 > 53\text{ mmHg} C O 2 ​ > 53 mmHg during sleep.

Sensor Sizing & Application:

Nasal cannula prongs must occupy no more than 50% of the nares to avoid creating artificial mechanical resistance or mouth breathing.

RIP effort belts must be appropriately sized and snug to prevent slippage on small chest walls.

Child-Centered Behavioral Preparation:

Technicians should employ age-appropriate language, demonstrate electrode placement on a stuffed animal ("medical play"), and bundle lead wires securely within tubular elastic netting ( Surgilast ) behind the child's clothing to prevent accidental dislodgement.

3. Home Sleep Apnea Testing (HSAT / OCST) Classifications

Out-of-Center Sleep Testing (OCST), commonly termed Home Sleep Apnea Testing (HSAT) , utilizes portable recording devices designed for unattended diagnostic evaluation of Obstructive Sleep Apnea in the patient's home environment. +-----------------------------------------------------------------------------+

  • | AASM / CMS SLEEP TESTING DEVICE CLASSIFICATION |
  • | |
  • | TYPE I: Comprehensive attended in-lab PSG (>= 7 channels including EEG) |
  • | TYPE II: Comprehensive unattended portable PSG (>= 7 channels with EEG) |
  • | TYPE III: Modified portable sleep apnea test (MINIMUM 4 CHANNELS): |
  • | - 2 Respiratory channels (airflow + respiratory effort) |
  • | - 1 Cardiac channel (heart rate or single-lead ECG) |
  • | - 1 Pulse Oximetry channel (oxygen saturation) |
  • | TYPE IV: Continuous 1 to 2 channel recording (e.g., oximetry alone, or |
  • | oximetry + airflow, or Peripheral Arterial Tone [PAT] devices) |
  • +-----------------------------------------------------------------------------+

Comparison of Sleep Testing Modalities:

Modality Environment Staffing Minimum Channels Primary Parameters Recorded Clinical Goal

Type I (In-Lab PSG) Sleep Laboratory Attended by Technologist ≥ 7 \ge 7 ≥ 7 EEG, EOG, EMG, ECG, Thermal/Pressure Airflow, Dual RIP Effort, S p O 2 SpO_2 Sp O 2 ​ , Body Position Gold standard; all sleep disorders (OSA, CSA, Narcolepsy, Parasomnias, Hypoventilation)

Type II (Portable PSG) Unattended (Home/Hospital) Unattended ≥ 7 \ge 7 ≥ 7 Full neurophysiological & respiratory montage (EEG, EOG, EMG, ECG, Airflow, Effort, S p O 2 SpO_2 Sp O 2 ​ ) Comprehensive evaluation when patient is non-ambulatory / ICU bound

Type III (HSAT) Unattended Home Unattended ≥ 4 \ge 4 ≥ 4 Airflow (pressure/thermal), RIP Effort, Heart Rate, S p O 2 SpO_2 Sp O 2 ​ Focused evaluation of suspected moderate-to-severe OSA in uncomplicated adults

Type IV (Single/Dual) Unattended Home Unattended 1 – 2 1\text{--}2 1 – 2 Oximetry alone, or PAT + Actigraphy + S p O 2 SpO_2 Sp O 2 ​ Screening or limited OSA assessment

4. Indications, Contraindications & Limitations of HSAT

The AASM Clinical Practice Guideline establishes strict clinical boundaries governing the appropriate utilization of HSAT. +-----------------------------------------------------------------------------+

  • | HSAT CLINICAL DECISION MATRIX |
  • | |
  • | APPROPRIATE INDICATIONS: |
  • | - High pre-test probability of uncomplicated moderate-to-severe OSA |
  • | - Documented by clinical history, loud snoring, witnessed apneas, |
  • | elevated Epworth (>10), and high STOP-BANG (>=5) |
  • | - Follow-up of response to oral appliances or surgical therapy |
  • | |
  • | ABSOLUTE & RELATIVE CONTRAINDICATIONS (MANDATE IN-LAB PSG): |
  • | - Significant comorbid pulmonary disease (COPD, severe asthma) |
  • | - Congestive Heart Failure (CHF, NYHA Class II-IV) |
  • | - Neuromuscular disease (ALS, myasthenia gravis, spinal cord injury) |
  • | - Suspected Central Sleep Apnea or Cheyne-Stokes Breathing |
  • | - Chronic high-dose opioid use |
  • | - Suspected Parasomnias, Nocturnal Seizures, or REM Behavior Disorder |
  • | - Suspected Narcolepsy or Idiopathic Hypersomnia |
  • | - Comorbid severe insomnia or circadian rhythm sleep-wake disorders |
  • | - Pediatric patients (< 18 years of age) |
  • +-----------------------------------------------------------------------------+

Critical Diagnostic Limitations of HSAT:

Absence of EEG (Cannot Stage Sleep):

HSAT devices lack electroencephalographic leads; therefore, sleep cannot be staged (no N1, N2, N3, or REM identification).

Total Sleep Time (TST) cannot be measured. Instead, the device calculates metrics based on Total Monitoring Time (TMT) or Total Recording Time (TRT) .

Respiratory Event Index (REI) vs. Apnea-Hypopnea Index (AHI):

In-lab PSG calculates true AHI = Apneas + Hypopneas Total Sleep Time (hours) \text{AHI} = \frac{\text{Apneas} + \text{Hypopneas}}{\text{Total Sleep Time (hours)}} AHI = Total Sleep Time (hours) Apneas + Hypopneas ​ .

HSAT calculates the Respiratory Event Index (REI) : REI = Total Apneas + Total Hypopneas Total Monitoring Time (hours) \text{REI} = \frac{\text{Total Apneas} + \text{Total Hypopneas}}{\text{Total Monitoring Time (hours)}} REI = Total Monitoring Time (hours) Total Apneas + Total Hypopneas ​

The Dilution Effect: If a patient with severe insomnia sleeps only 3 hours during an 8-hour HSAT monitoring period, all respiratory events are divided by 8 hours instead of 3 hours. This artificially dilutes the event index, potentially turning severe OSA into a false-negative normal study.

Hypopnea Scoring Limitations:

On Type I PSG, hypopneas can be scored if associated with either ≥ 3 % \ge 3\% ≥ 3% oxygen desaturation OR an electroencephalographic cortical arousal.

On standard Type III HSAT, cortical arousals cannot be detected; therefore, only desaturation-based hypopneas ( ≥ 3 % \ge 3\% ≥ 3% or ≥ 4 % \ge 4\% ≥ 4% ) can be scored , leading to systematic underestimation of milder respiratory events.

Mandatory In-Lab Follow-Up:

If an HSAT returns negative, inconclusive, or technically inadequate in a patient with persistent clinical symptoms of sleep apnea, an attended in-laboratory polysomnography (Type I) is medically mandatory to establish a definitive diagnosis.

Loading diagram... Diagnostic Sleep Testing Modality Selection Algorithm